December 2-4, 2013 | London, UK | Tumour Models Meeting

 

 

Jean-Gabriel Judde, CSO and founder of XenTech, will be attending the Tumour Models Meeting to be held in London in December.

 

This meeting focuses on the challenges drug developers are facing as they look to develop more predictive preclinical models. This is a unique opportunity to discuss how PDXs may minimize late stage clinical attrition, improve treatment predictability and foster the development of cancer therapies.

 

Contact us to schedule a meeting Jean-Gabriel Judde.